FDA recall record

Siemens Healthcare Diagnostics ADVIA Centaur aTPO Assay, Material Number 10630886 (100 Test) recall — FDA Z-3304-2024

Positive bias in patient results at and below the cut-off of 60 U/mL with the lots listed in the table below when compared to alternate lots on the…

Class IIclassification
Z-3304-2024official record ID
Oct 9, 2024report date

Recall record at a glance

Official recordZ-3304-2024
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmSiemens Healthcare Diagnostics, Inc.
Report dateOct 9, 2024
Recall initiation dateAug 21, 2024
Quantity5622 kits
LocationTarrytown, NY, United States

Official product description

ADVIA Centaur aTPO Assay, Material Number 10630886 (100 Test) and 10630887 (500 Test)

Why the product was recalled

Positive bias in patient results at and below the cut-off of 60 U/mL with the lots listed in the table below when compared to alternate lots on the Atellica IM analyzer.

Distribution information

Worldwide distribution - US Nationwide.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.